The Drugs Controller General of India (DCGI) has given a restricted emergency use authorisation to Bharat Biotech's Covaxin for children aged 6-12 years, ANI news agency reported on Tuesday (April 26, 2022).
Covid 4th wave: DCGI approves emergency use of Bharat Biotech s Covaxin for children aged 6-12 years - DCGI has approved the emergency use authorisation for Bharat Biotech s Covaxin for children aged 6-12 years.
Speaking exclusively with India Today, top virologist Gagandeep Kang said there is no urgent need to vaccinate children against Covid-19 as the trials are still continuing.